# Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

Study · id `cardio:ct-nct05514548` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05514548](<https://clinicaltrials.gov/study/NCT05514548>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05514548

Browse, organ or system: Kidneys; Metabolism  
Browse, condition area: Diabetes and metabolic disease; Kidney connections  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 265 participants.

## Technical summary

Registry record NCT05514548. Randomized; triple masking; primary purpose treatment. Start 2022-10-19 (actual); primary completion 2024-08-20 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 265 participants (enrolled count; ClinicalTrials.gov record NCT05514548, source copy `cardio:ctgov-nct05514548-2025-08-11`, retrieved 2026-10-26)
- Started: 2022-10-19 (actual) (ClinicalTrials.gov record NCT05514548, source copy `cardio:ctgov-nct05514548-2025-08-11`, retrieved 2026-10-26)
- Primary completion: 2024-08-20 (actual) (ClinicalTrials.gov record NCT05514548, source copy `cardio:ctgov-nct05514548-2025-08-11`, retrieved 2026-10-26)
- Completion: 2024-09-03 (actual) (ClinicalTrials.gov record NCT05514548, source copy `cardio:ctgov-nct05514548-2025-08-11`, retrieved 2026-10-26)
- Countries: United States; Canada; Georgia; Hungary; Israel; Mexico; Serbia (ClinicalTrials.gov record NCT05514548, source copy `cardio:ctgov-nct05514548-2025-08-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05514548-2025-08-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease
- Condition: Diabetic Kidney Disease
- Intervention (Drug): INV-202
- Intervention (Drug): Placebo
- Lead sponsor: Inversago Pharma Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: Worldwide Clinical Trials
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Diabetic kidney disease (`cardio:diabetic-nephropathy`)
- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry condition terms include this condition: Type 1 diabetes (`core:type-1-diabetes`)
- Registry lists this organization as a collaborator: Worldwide Clinical Trials (`cardio:org-worldwide-clinical-trials`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: A double-blind, randomized, placebo-controlled, phase 2 trial examined the efficacy and safety of monlunabant in adults with diabetic kidney disease (`cardio:pubmed-41866124`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 3f1de5ccf3f4866be11bded7297ea9f854c7531218ed7cc097a0de87846f9eb8
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
